Brooke S West1, Enrique R Pouget2, Barbara Tempalski2, Hannah L F Cooper3, H Irene Hall4, Xiaohong Hu4, Samuel R Friedman2. 1. Division of Global Public Health, School of Medicine, University of California, San Diego, La Jolla, CA. Electronic address: bswest@ucsd.edu. 2. National Development and Research Institutes, Inc., New York, NY. 3. Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA. 4. Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
PURPOSE: We estimated female and male incident AIDS diagnosis rates (IARs) among people who inject drugs (PWID) in U.S. metropolitan statistical areas (MSAs) over time to assess whether declines in IARs varied by sex after combination antiretroviral therapy (cART) dissemination. METHODS: We compared IARs and 95% confidence intervals for female and male PWID in 95 of the most populous MSAs. To stabilize estimates, we aggregated data across three-year periods, selecting a period immediately preceding cART (1993-1995) and the most recent after the introduction of cART for which data were available (2005-2007). We assessed disparities by comparing IAR 95% confidence intervals for overlap, female-to-male risk ratios, and disparity change scores. RESULTS: IARs declined an average of 58% for female PWID and 67% for male PWID between the pre-cART and cART periods. Among female PWID, IARs were significantly lower in the later period relative to the pre-cART period in 48% of MSAs. Among male PWID, IARs were significantly lower over time in 86% of MSAs. CONCLUSIONS: IARs among female PWID in large U.S. MSAs have declined more slowly than among male PWID. This suggests a need for increased targeting of prevention and treatment programs and for research on MSA level conditions that may drive differences in declining AIDS rates among female and male PWID.
PURPOSE: We estimated female and male incident AIDS diagnosis rates (IARs) among people who inject drugs (PWID) in U.S. metropolitan statistical areas (MSAs) over time to assess whether declines in IARs varied by sex after combination antiretroviral therapy (cART) dissemination. METHODS: We compared IARs and 95% confidence intervals for female and male PWID in 95 of the most populous MSAs. To stabilize estimates, we aggregated data across three-year periods, selecting a period immediately preceding cART (1993-1995) and the most recent after the introduction of cART for which data were available (2005-2007). We assessed disparities by comparing IAR 95% confidence intervals for overlap, female-to-male risk ratios, and disparity change scores. RESULTS: IARs declined an average of 58% for female PWID and 67% for male PWID between the pre-cART and cART periods. Among female PWID, IARs were significantly lower in the later period relative to the pre-cART period in 48% of MSAs. Among male PWID, IARs were significantly lower over time in 86% of MSAs. CONCLUSIONS: IARs among female PWID in large U.S. MSAs have declined more slowly than among male PWID. This suggests a need for increased targeting of prevention and treatment programs and for research on MSA level conditions that may drive differences in declining AIDS rates among female and male PWID.
Authors: J E Kaplan; D Hanson; M S Dworkin; T Frederick; J Bertolli; M L Lindegren; S Holmberg; J L Jones Journal: Clin Infect Dis Date: 2000-04 Impact factor: 9.079
Authors: A M Cescon; C Cooper; K Chan; A K Palmer; M B Klein; N Machouf; M R Loutfy; J Raboud; A Rachlis; E Ding; V D Lima; J S G Montaner; S B Rourke; M Smieja; C Tsoukas; R S Hogg Journal: HIV Med Date: 2010-11-08 Impact factor: 3.180
Authors: Diana C Lemly; Bryan E Shepherd; Todd Hulgan; Peter Rebeiro; Samuel Stinnette; Robert B Blackwell; Sally Bebawy; Asghar Kheshti; Timothy R Sterling; Stephen P Raffanti Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: Enrique R Pouget; Brooke S West; Barbara Tempalski; Hannah L F Cooper; H Irene Hall; Xiaohong Hu; Samuel R Friedman Journal: Public Health Rep Date: 2014-05 Impact factor: 2.792
Authors: Samuel R Friedman; Brooke S West; Enrique R Pouget; H Irene Hall; Jennifer Cantrell; Barbara Tempalski; Sudip Chatterjee; Xiaohong Hu; Hannah L F Cooper; Sandro Galea; Don C Des Jarlais Journal: PLoS One Date: 2013-02-21 Impact factor: 3.240
Authors: Barbara Tempalski; Enrique R Pouget; Charles M Cleland; Joanne E Brady; Hannah L F Cooper; H Irene Hall; Amy Lansky; Brooke S West; Samuel R Friedman Journal: PLoS One Date: 2013-06-05 Impact factor: 3.240
Authors: Samuel R Friedman; Barbara Tempalski; Joanne E Brady; Brooke S West; Enrique R Pouget; Leslie D Williams; Don C Des Jarlais; Hannah L F Cooper Journal: Int J Drug Policy Date: 2016-03-11